Dow Up 0.76% Nasdaq Up 0.69%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
9.37 Up 0.25(2.69%) Oct 24, 4:00PM EDT
|After Hours : 9.44 Up 0.08 (0.80%) Oct 24, 7:43PM EDT
Prev Close:9.12
Open:9.14
Bid:N/A
Ask:9.88 x 600
1y Target Est:14.00
Beta:1.23
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:8.95 - 9.45
52wk Range:2.05 - 9.45
Volume:2,728,826
Avg Vol (3m):1,988,300
Market Cap:979.46M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MACKUp 2.69%979.46M
IMMUUp 0.53%351.97M
LRUSF 0.00%N/A
THLDUp 1.01%178.69M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.78
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-2.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback